Chemours Company(CC)
$13.72+0.24 (+1.78%)
CC
Chemours Company financials statements
$13.72
At close:+0.24 (+1.78%)
Want to see CC full AI Analyst Report?
Chemours Company (CC) Ratios
1,448 Followers
Chemours Company Ratios
CC's free cash flow for Q3 2026 was $98.00M. For the 2026 fiscal year, CC's free cash flow was decreased by $-51.00M and operating cash flow was $149.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.78 | 1.68 | 1.54 | 1.70 | 1.80 |
| Quick Ratio | 0.85 | 0.86 | 1.00 | 0.96 | 1.21 |
| Cash Ratio | 0.40 | 0.40 | 0.48 | 0.58 | 0.78 |
| Solvency Ratio | -0.01 | 0.06 | 0.01 | 0.13 | 0.14 |
| Operating Cash Flow Ratio | 0.16 | -0.35 | 0.22 | 0.40 | 0.44 |
| Short-Term Operating Cash Flow Coverage | 2.54 | -11.72 | 10.90 | 17.56 | 32.56 |
| Net Current Asset Value | $ -4.13B | $ -3.88B | $ -3.68B | $ -3.32B | $ -3.12B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.62 | 0.58 | 0.52 | 0.51 | 0.53 |
| Debt-to-Equity Ratio | 18.34 | 7.21 | 5.83 | 3.50 | 3.69 |
| Debt-to-Capital Ratio | 0.95 | 0.88 | 0.85 | 0.78 | 0.79 |
| Long-Term Debt-to-Capital Ratio | 0.94 | 0.87 | 0.84 | 0.76 | 0.78 |
| Financial Leverage Ratio | 29.53 | 12.44 | 11.20 | 6.90 | 6.98 |
| Debt Service Coverage Ratio | 0.60 | 2.05 | 1.07 | 5.01 | 5.29 |
| Interest Coverage Ratio | -0.02 | 1.68 | -0.59 | 4.82 | 3.64 |
| Debt to Market Cap | 2.46 | 1.61 | 0.85 | 0.76 | 0.68 |
| Interest Debt Per Share | 32.28 | 30.90 | 30.27 | 26.02 | 25.29 |
| Net Debt to EBITDA | 11.79 | 5.26 | 15.72 | 2.32 | 2.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.53% | 19.91% | 21.49% | 23.66% | 21.77% |
| EBIT Margin | -0.14% | 6.76% | -1.81% | 13.23% | 13.57% |
| EBITDA Margin | 5.72% | 11.97% | 3.24% | 17.49% | 18.57% |
| Operating Profit Margin | -0.09% | 7.66% | -2.02% | 11.51% | 10.62% |
| Pretax Profit Margin | -4.77% | 2.20% | -5.23% | 10.85% | 10.65% |
| Net Profit Margin | -6.65% | 1.49% | -3.92% | 8.46% | 9.58% |
| Continuous Operations Profit Margin | -6.65% | 1.49% | -3.90% | 8.46% | 9.58% |
| Net Income Per EBT | 139.35% | 67.72% | 74.84% | 78.00% | 89.94% |
| EBT Per EBIT | 5540.00% | 28.67% | 258.54% | 94.27% | 100.30% |
| Return on Assets (ROA) | -5.23% | 1.14% | -2.88% | 7.57% | 8.05% |
| Return on Equity (ROE) | -154.40% | 14.24% | -32.29% | 52.21% | 56.24% |
| Return on Capital Employed (ROCE) | -0.09% | 7.76% | -2.13% | 13.67% | 11.84% |
| Return on Invested Capital (ROIC) | -0.09% | 5.16% | -1.56% | 10.50% | 10.50% |
| Return on Tangible Assets | -5.26% | 1.15% | -2.92% | 7.68% | 8.17% |
| Earnings Yield | -21.78% | 3.40% | -5.07% | 12.15% | 10.98% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.55 | 7.51 | 9.96 | 10.91 | 8.81 |
| Payables Turnover | 5.28 | 4.13 | 4.21 | 4.31 | 4.35 |
| Inventory Turnover | 3.13 | 3.15 | 3.53 | 3.71 | 4.52 |
| Fixed Asset Turnover | 1.73 | 1.68 | 1.75 | 2.00 | 1.88 |
| Asset Turnover | 0.79 | 0.77 | 0.74 | 0.89 | 0.84 |
| Working Capital Turnover Ratio | 4.58 | 4.50 | 4.55 | 4.86 | 4.74 |
| Cash Conversion Cycle | 90.29 | 76.35 | 53.31 | 47.03 | 38.33 |
| Days of Sales Outstanding | 42.67 | 48.61 | 36.63 | 33.45 | 41.42 |
| Days of Inventory Outstanding | 116.73 | 116.02 | 103.41 | 98.27 | 80.81 |
| Days of Payables Outstanding | 69.12 | 88.27 | 86.74 | 84.69 | 83.90 |
| Operating Cycle | 159.40 | 164.63 | 140.04 | 131.72 | 122.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.76 | -4.23 | 3.73 | 4.86 | 4.94 |
| Free Cash Flow Per Share | 0.34 | -6.64 | 1.25 | 2.88 | 3.26 |
| Dividend Paid and CapEx Coverage Ratio | 0.91 | -1.25 | 1.07 | 1.64 | 1.85 |
| Capital Expenditure Coverage Ratio | 1.24 | -1.76 | 1.50 | 2.46 | 2.94 |
| Operating Cash Flow Coverage Ratio | 0.06 | -0.15 | 0.13 | 0.19 | 0.20 |
| Operating Cash Flow to Sales Ratio | 0.05 | -0.11 | 0.09 | 0.11 | 0.13 |
| Free Cash Flow Yield | 2.88% | -39.30% | 3.96% | 9.42% | 9.70% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.59 | 29.38 | -19.73 | 8.23 | 9.10 |
| Price-to-Sales (P/S) Ratio | 0.31 | 0.44 | 0.77 | 0.70 | 0.87 |
| Price-to-Book (P/B) Ratio | 7.09 | 4.18 | 6.37 | 4.30 | 5.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 34.76 | -2.54 | 25.25 | 10.62 | 10.31 |
| Price-to-Operating Cash Flow Ratio | 6.71 | -3.99 | 8.45 | 6.30 | 6.80 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -0.22 | 0.14 | 10.12 | 0.05 |
| Enterprise Value Multiple | 17.13 | 8.91 | 39.56 | 6.31 | 6.85 |
| Enterprise Value | 5.69B | 6.17B | 7.79B | 7.54B | 8.07B |
| EV to EBITDA | 17.13 | 8.91 | 39.56 | 6.31 | 6.85 |
| EV to Sales | 0.98 | 1.07 | 1.28 | 1.10 | 1.27 |
| EV to Free Cash Flow | 111.48 | -6.21 | 41.90 | 16.82 | 15.03 |
| EV to Operating Cash Flow | 21.54 | -9.74 | 14.02 | 9.98 | 9.92 |
| Tangible Book Value Per Share | 1.35 | 3.72 | 4.26 | 6.39 | 5.91 |
| Shareholders’ Equity Per Share | 1.66 | 4.04 | 4.95 | 7.13 | 6.55 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.39 | 0.32 | 0.25 | 0.22 | 0.10 |
| Revenue Per Share | 38.63 | 38.68 | 40.82 | 43.97 | 38.47 |
| Net Income Per Share | -2.57 | 0.58 | -1.60 | 3.72 | 3.69 |
| Tax Burden | 1.39 | 0.68 | 0.75 | 0.78 | 0.90 |
| Interest Burden | 34.63 | 0.32 | 2.89 | 0.82 | 0.79 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.14 | 0.10 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | -0.68 | -7.36 | -2.34 | 1.31 | 1.34 |
Currency in USD
